You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 287 No. 11, March 20, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Scientific Review and Clinical Applications
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (58)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CLINICIAN'S CORNER
{beta}-Blockers and Reduction of Cardiac Events in Noncardiac Surgery

Clinical Applications

Andrew D. Auerbach, MD,MPH; Lee Goldman, MD

JAMA. 2002;287:1445-1447.

Recent studies suggest that {beta}-blockers administered perioperatively may reduce the risk of adverse cardiac events and mortality in patients who have cardiac risk factors and undergo major noncardiac surgery. The objective of this article is to provide practicing physicians with examples of perioperative {beta}-blocker use in practice by using several hypothetical cases. Although current evidence describing the effectiveness of perioperative {beta}-blockade may not address all possible clinical situations, it is possible to formulate an evidence-based approach that will maximize benefit to patients. We describe how information from several sources can be used to guide management of patients with limited exercise tolerance, those at highest risk for perioperative cardiac events, patients who are taking {beta}-blockers long-term, and those with relative contraindications to {beta}-blockade. Even though fine points of their use remain to be elucidated, perioperative {beta}-blocker use is important and can be easily applied in practice by any physician involved with the care of patients perioperatively.


Author Affiliations: Department of Medicine, University of California, San Francisco.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

{beta}-Blockers and Reduction of Cardiac Events in Noncardiac Surgery: Scientific Review
Andrew D. Auerbach and Lee Goldman
JAMA. 2002;287(11):1435-1444.
ABSTRACT | FULL TEXT  

March 20, 2002
JAMA. 2002;287(11):1469-1470.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Effect of Angiotensin-Converting Enzyme Inhibitor on Hemodynamic Instability in Patients Undergoing Cardiopulmonary Bypass: Results of a Dose-Comparison Study
Shahzamani et al.
J CARDIOVASC PHARMACOL THER 2009;14:185-191.
ABSTRACT  

Reducing cardiac risk in non-cardiac surgery: evidence from the DECREASE studies
Poldermans et al.
Eur Heart J Suppl 2009;11:A9-A14.
ABSTRACT | FULL TEXT  

Perioperative {beta}-Blockade: How Best to Translate Evidence into Practice
Fleisher
Anesth. Analg. 2007;104:1-3.
FULL TEXT  

Any Need for Preoperative Cardiac Testing in Intermediate-Risk Patients With Tight Beta-Adrenergic Blockade?
Eagle and Lau
J Am Coll Cardiol 2006;48:970-972.
FULL TEXT  

What the surgeon of tomorrow needs to know about evidence-based surgery.
Maier
Arch Surg 2006;141:317-323.
FULL TEXT  

Perioperative Sublingual Isosorbide Dinitrate for the Prevention of Cardiac Complications in Cardiac Patients Undergoing Noncardiac Surgery
RuDusky
ANGIOLOGY 2005;56:755-760.
ABSTRACT  

{beta} blockers for patients at risk of cardiac events during non-cardiac surgery
Bolsin and Colson
BMJ 2005;331:919-920.
FULL TEXT  

Pharmacologic prophylaxis for postoperative atrial tachyarrhythmia in general thoracic surgery: Evidence from randomized clinical trials
Sedrakyan et al.
J. Thorac. Cardiovasc. Surg. 2005;129:997-1005.
ABSTRACT | FULL TEXT  

Angiotensin System Inhibitors in a General Surgical Population
Comfere et al.
Anesth. Analg. 2005;100:636-644.
ABSTRACT | FULL TEXT  

Role of {beta}-blockade in anaesthesia and postoperative pain management after hysterectomy
Chia et al.
Br J Anaesth 2004;93:799-805.
ABSTRACT | FULL TEXT  

Cardiac troponin after major vascular surgery: The role of perioperative ischemia, preoperative thallium scanning, and coronary revascularization
Landesberg et al.
J Am Coll Cardiol 2004;44:569-575.
ABSTRACT | FULL TEXT  

Contemporary Management of Chronic Obstructive Pulmonary Disease: Scientific Review
Sin et al.
JAMA 2003;290:2301-2312.
ABSTRACT | FULL TEXT  

Pharmacologic Myocardial Protection in Patients Undergoing Noncardiac Surgery: A Quantitative Systematic Review
Stevens et al.
Anesth. Analg. 2003;97:623-633.
ABSTRACT | FULL TEXT  

Knowledge and Practice Regarding Prophylactic Perioperative Beta Blockade in Patients Undergoing Noncardiac Surgery: A Survey of Canadian Anesthesiologists
VanDenKerkhof et al.
Anesth. Analg. 2003;96:1558-1565.
ABSTRACT | FULL TEXT  

The Impact of a Cardioprotective Protocol on the Incidence of Cardiac Complications After Aortic Abdominal Surgery
Licker et al.
Anesth. Analg. 2002;95:1525-1533.
ABSTRACT | FULL TEXT  

Perioperative Evaluation of Patients Undergoing Noncardiac Surgery
JWatch General 2002;2002:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.